| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
26,630 |
24,258 |
$1.99M |
| G0466 |
Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
3,901 |
3,894 |
$303K |
| G0470 |
Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit |
2,240 |
1,364 |
$176K |
| 99000 |
|
9,425 |
9,067 |
$84K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,259 |
18,821 |
$45K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
3,671 |
3,548 |
$22K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,074 |
1,049 |
$19K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,868 |
4,736 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,799 |
1,799 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,578 |
4,476 |
$4K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
279 |
267 |
$3K |
| 81003 |
|
2,961 |
2,880 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
586 |
585 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,243 |
1,241 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,141 |
1,088 |
$2K |
| 81025 |
|
1,418 |
1,380 |
$2K |
| 91322 |
|
17 |
17 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
501 |
500 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,957 |
1,869 |
$800.85 |
| 90837 |
Psychotherapy, 53 minutes with patient |
305 |
155 |
$744.69 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
261 |
260 |
$727.46 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
573 |
557 |
$660.40 |
| 0124A |
|
43 |
43 |
$657.58 |
| 90832 |
Psychotherapy, 30 minutes with patient |
883 |
624 |
$630.73 |
| 98966 |
|
119 |
104 |
$606.75 |
| 90480 |
|
30 |
30 |
$508.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
524 |
519 |
$442.90 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
538 |
528 |
$425.01 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
39 |
39 |
$391.51 |
| 99406 |
|
808 |
771 |
$259.31 |
| 99215 |
Prolong outpt/office vis |
73 |
73 |
$174.15 |
| 90834 |
Psychotherapy, 45 minutes with patient |
100 |
81 |
$122.43 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
83 |
83 |
$101.00 |
| 99384 |
|
12 |
12 |
$101.00 |
| 96156 |
|
73 |
71 |
$82.92 |
| 90714 |
|
12 |
12 |
$56.02 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
444 |
444 |
$54.97 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
13 |
13 |
$50.32 |
| 82947 |
|
386 |
384 |
$19.70 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
12 |
12 |
$19.45 |
| 36416 |
|
620 |
616 |
$11.37 |
| 92551 |
|
118 |
116 |
$5.73 |
| 87210 |
|
12 |
12 |
$4.82 |
| 90791 |
Psychiatric diagnostic evaluation |
141 |
141 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
521 |
512 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
14 |
14 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
12 |
12 |
$0.00 |
| 94760 |
|
8,457 |
8,127 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,064 |
1,051 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
29 |
29 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
27 |
27 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
13 |
$0.00 |